GlassScriptPhysician profile
Katrina Metcalf
NPI 1114445657
$4,941.13
in general payments reported to CMS, 2019-2025
15 companies · $239 in 2025
The $239 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $834 · 2022: $2,251 · 2023: $218 · 2024: $1,399 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,031 · Travel and Lodging: $825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,030.81 |
| Travel and Lodging | $825.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,394.00 | 2021-2025 | Mitraclip, Gallant, Jot Dx |
| Medtronic, INC. | $1,515.62 | 2022-2023 | Micra |
| Boston Scientific Corporation | $375.58 | 2021-2025 | Watchman Access System, Watchman |
| Amgen INC. | $155.81 | 2021-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $99.18 | 2021-2025 | Camzyos |
| Tactile Systems Technology INC | $76.37 | 2021-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Janssen Pharmaceuticals, INC | $66.43 | 2021-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $58.84 | 2021-2023 | Lifevest |
| Merck Sharp & Dohme LLC | $53.04 | 2021-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $43.94 | 2021-2024 | Lokelma |
| Pfizer INC. | $31.27 | 2021 | |
| Bardy Diagnostics, INC. | $20.66 | 2021 | |
| Novartis Pharmaceuticals Corporation | $20.07 | 2022 | |
| Sanofi-Aventis U.S. LLC | $16.00 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $14.32 | 2025 | Uptravi, Opsumit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katrina Metcalf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.